Susanne Malander
11 – 20 of 45
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Copy number signatures for early diagnosis of high-grade serous ovarian carcinoma
(2022) “FUTURE PERSPECTIVES IN OVARIAN CANCER RESEARCH”
- Contribution to conference › Poster
-
Mark
Prognostic value of peritoneal cancer index after complete cytoreductive suergery in advanced ovarian cancer
- Contribution to journal › Published meeting abstract
-
Mark
Ovarian tumor frozen section, a multidisciplinary affair
- Contribution to journal › Published meeting abstract
- 2021
-
Mark
Incidence and survival of epithelial ovarian, fallopian tube, peritoneal, and undesignated abdominal/pelvic cancers in Sweden 1960–2014 : A population-based cohort study
- Contribution to journal › Article
-
Mark
MET Expression and Cancer Stem Cell Networks Impact Outcome in High-Grade Serous Ovarian Cancer
- Contribution to journal › Article
- 2020
-
Mark
SOX2 is a promising predictor of relapse and death in advanced stage high-grade serous ovarian cancer patients with residual disease after debulking surgery
- Contribution to journal › Article
-
Mark
A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients
- Contribution to journal › Article
-
Mark
PD-1/PD-L1 expression and tumor-infiltrating lymphocytes are prognostically favorable in advanced high-grade serous ovarian carcinoma
- Contribution to journal › Article
-
Mark
High density of stroma-localized CD11c-positive macrophages is associated with longer overall survival in high-grade serous ovarian cancer
- Contribution to journal › Article
- 2019
-
Mark
A targeted mass spectrometry strategy for developing proteomic biomarkers : a case study of epithelial ovarian cancer
- Contribution to journal › Article
